Company intelligence / Profile preview

Trapelo Health

Waltham, Massachusetts, United Statestrapelohealth.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company developed a commercial precision medicine software platform that enables real-time alignment among oncologists, molecular labs, and payers to optimize the use of molecular diagnostics and targeted therapies for cancer patients. Their flagship product helps match patient-specific tumor genomics with evidence-based treatment options. No clinical trial results as the company provides health IT/software rather than direct therapeutics.

Therapeutic areas: Oncology
Industry: Digital Health Medical Devices

Partnerships

Partnerships with community oncologistsmolecular diagnostic laboratoriespayers

Beyond the preview

Go deeper on Trapelo Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trapelo Health.

Explore the full profile